Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Association of Surgical Volume and Quality Management in Thyroid Surgery: A Two-Nation Multicenter Study.

Jakob DA, Riss P, Scheuba C, Hermann M, Kim-Fuchs C, Seiler CA, Walter MA, Kaderli RM.

World J Surg. 2019 Apr 22. doi: 10.1007/s00268-019-05012-z. [Epub ahead of print]

PMID:
31011819
2.

Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis.

Kaderli RM, Spanjol M, Kollár A, Bütikofer L, Gloy V, Dumont RA, Seiler CA, Christ ER, Radojewski P, Briel M, Walter MA.

JAMA Oncol. 2019 Feb 14. doi: 10.1001/jamaoncol.2018.6720. [Epub ahead of print]

PMID:
30763436
3.

Non-Synonymous variants in premelanosome protein (PMEL) cause ocular pigment dispersion and pigmentary glaucoma.

Lahola-Chomiak AA, Footz T, Nguyen-Phuoc K, Neil GJ, Fan B, Allen KF, Greenfield DS, Parrish RK, Linkroum K, Pasquale LR, Leonhardt RM, Ritch R, Javadiyan S, Craig JE, Allison WT, Lehmann OJ, Walter MA, Wiggs JL.

Hum Mol Genet. 2019 Apr 15;28(8):1298-1311. doi: 10.1093/hmg/ddy429.

PMID:
30561643
4.

FOXF2 is required for cochlear development in humans and mice.

Bademci G, Abad C, Incesulu A, Elian F, Reyahi A, Diaz-Horta O, Cengiz FB, Sineni CJ, Seyhan S, Atli EI, Basmak H, Demir S, Nik AM, Footz T, Guo S, Duman D, Fitoz S, Gurkan H, Blanton SH, Walter MA, Carlsson P, Walz K, Tekin M.

Hum Mol Genet. 2019 Apr 15;28(8):1286-1297. doi: 10.1093/hmg/ddy431.

PMID:
30561639
5.

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study.

Carlsen EA, Fazio N, Granberg D, Grozinsky-Glasberg S, Ahmadzadehfar H, Grana CM, Zandee WT, Cwikla J, Walter MA, Oturai PS, Rinke A, Weaver A, Frilling A, Gritti S, Arveschoug AK, Meirovitz A, Knigge U, Sorbye H.

Endocr Relat Cancer. 2019 Feb 1;26(2):227-239. doi: 10.1530/ERC-18-0424.

PMID:
30540557
6.

MEK inhibition induces therapeutic iodine uptake in a murine model of anaplastic thyroid cancer.

ElMokh O, Taelmann V, Radojewski P, Roelli MA, Stooss A, Dumont RA, Dettmer M, Phillips W, Walter MA, Charles RR.

J Nucl Med. 2018 Nov 21. pii: jnumed.118.216721. doi: 10.2967/jnumed.118.216721. [Epub ahead of print]

PMID:
30464041
7.

Accuracy of whole-body HDP SPECT/CT, FDG PET/CT, and their combination for detecting bone metastases in breast cancer: an intra-personal comparison.

Rager O, Lee-Felker SA, Tabouret-Viaud C, Felker ER, Poncet A, Amzalag G, Garibotto V, Zaidi H, Walter MA.

Am J Nucl Med Mol Imaging. 2018 Jun 5;8(3):159-168. eCollection 2018.

8.

FOXC1 Regulates Expression of Prostaglandin Receptors Leading to an Attenuated Response to Latanoprost.

Doucette LP, Footz T, Walter MA.

Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2548-2554. doi: 10.1167/iovs.17-23223.

PMID:
29847662
9.

Molecular Genetics of Pigment Dispersion Syndrome and Pigmentary Glaucoma: New Insights into Mechanisms.

Lahola-Chomiak AA, Walter MA.

J Ophthalmol. 2018 Mar 26;2018:5926906. doi: 10.1155/2018/5926906. eCollection 2018. Review.

10.

Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in silico bioinformatics algorithms.

Seifi M, Walter MA.

PLoS One. 2018 Apr 17;13(4):e0195971. doi: 10.1371/journal.pone.0195971. eCollection 2018.

11.

[Somatostatin receptor PET/CT (SSTR-PET/CT)].

Boy C, Poeppel T, Kotzerke J, Krause BJ, Amthauer H, Baum RP, Buchmann I, Ezziddin S, Führer D, Gabriel M, Kuwert T, Lahner H, Lauenstein T, Maecke HR, Nagarajah J, Rösch F, Scheidhauer K, Schmidt M, Walter MA, Bockisch A.

Nuklearmedizin. 2018 Feb;57(1):4-17. doi: 10.1055/s-0038-1636560. Epub 2018 Feb 21. German.

PMID:
29536494
12.

Delafloxacin meglumine, Meropenem trihydrate/vaborbactam, Secnidazole, and Benznidazole.

Hussar DA, Walter MA.

J Am Pharm Assoc (2003). 2018 Mar - Apr;58(2):223-227. doi: 10.1016/j.japh.2018.01.007. No abstract available.

PMID:
29506662
13.

FOXC1, the new player in the cancer sandbox.

Elian FA, Yan E, Walter MA.

Oncotarget. 2017 Nov 28;9(8):8165-8178. doi: 10.18632/oncotarget.22742. eCollection 2018 Jan 30. Review.

14.

Clinical Aspects of Miscarriage.

Walter MA, Alvarado MS.

MCN Am J Matern Child Nurs. 2018 Jan/Feb;43(1):6-12. doi: 10.1097/NMC.0000000000000390.

PMID:
29049054
15.

Axenfeld-Rieger syndrome.

Seifi M, Walter MA.

Clin Genet. 2018 Jun;93(6):1123-1130. doi: 10.1111/cge.13148. Epub 2018 Jan 25. Review.

PMID:
28972279
16.

Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma.

Protas ME, Weh E, Footz T, Kasberger J, Baraban SC, Levin AV, Katz LJ, Ritch R, Walter MA, Semina EV, Gould DB.

Hum Mol Genet. 2017 Sep 15;26(18):3630-3638. doi: 10.1093/hmg/ddx251.

17.

FOXC1 modulates MYOC secretion through regulation of the exocytic proteins RAB3GAP1, RAB3GAP2 and SNAP25.

Rasnitsyn A, Doucette L, Seifi M, Footz T, Raymond V, Walter MA.

PLoS One. 2017 Jun 2;12(6):e0178518. doi: 10.1371/journal.pone.0178518. eCollection 2017.

18.

Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study.

Schandelmaier S, Tomonaga Y, Bassler D, Meerpohl JJ, von Elm E, You JJ, Bluemle A, Lamontagne F, Saccilotto R, Amstutz A, Bengough T, Stegert M, Olu KK, Tikkinen KAO, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Busse JW, Ferreira-González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Guyatt G, Bucher HC, Kasenda B, Briel M.

J Pediatr. 2017 May;184:209-214.e1. doi: 10.1016/j.jpeds.2017.01.071. Epub 2017 Mar 3.

PMID:
28410086
19.

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.

Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, Ngeow J, Wellner U, Malinoc A, Taschin E, Barbon G, Lanza V, Söderkvist P, Stenman A, Larsson C, Svahn F, Chen JL, Marquard J, Fraenkel M, Walter MA, Peczkowska M, Prejbisz A, Jarzab B, Hasse-Lazar K, Petersenn S, Moeller LC, Meyer A, Reisch N, Trupka A, Brase C, Galiano M, Preuss SF, Kwok P, Lendvai N, Berisha G, Makay Ö, Boedeker CC, Weryha G, Racz K, Januszewicz A, Walz MK, Gimm O, Opocher G, Eng C, Neumann HPH; European-American-Asian Pheochromocytoma-Paraganglioma Registry Study Group.

JAMA Oncol. 2017 Sep 1;3(9):1204-1212. doi: 10.1001/jamaoncol.2017.0223.

20.

Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic Issues.

Umlauft M, Radojewski P, Spanjol PM, Dumont R, Marincek N, Kollar A, Brunner P, Beyersmann J, Müller-Brand J, Maecke HR, Laimer M, Walter MA.

J Nucl Med. 2017 Sep;58(9):1532. doi: 10.2967/jnumed.117.190660. Epub 2017 Mar 9. No abstract available.

21.

Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation.

Bone HG, Walter MA, Hurley ME, Epstein S.

Osteoporos Int. 2017 May;28(5):1745-1752. doi: 10.1007/s00198-017-3941-3. Epub 2017 Feb 16.

22.

Comparison of Bioinformatics Prediction, Molecular Modeling, and Functional Analyses of FOXC1 Mutations in Patients with Axenfeld-Rieger Syndrome.

Seifi M, Footz T, Taylor SA, Walter MA.

Hum Mutat. 2017 Feb;38(2):169-179. doi: 10.1002/humu.23141. Epub 2016 Nov 21.

PMID:
27804176
23.

Upregulation of Key Molecules for Targeted Imaging and Therapy.

Taelman VF, Radojewski P, Marincek N, Ben-Shlomo A, Grotzky A, Olariu CI, Perren A, Stettler C, Krause T, Meier LP, Cescato R, Walter MA.

J Nucl Med. 2016 Nov;57(11):1805-1810. Epub 2016 Jun 30.

24.

Novel PITX2 gene mutations in patients with Axenfeld-Rieger syndrome.

Seifi M, Footz T, Taylor SA, Elhady GM, Abdalla EM, Walter MA.

Acta Ophthalmol. 2016 Nov;94(7):e571-e579. doi: 10.1111/aos.13030. Epub 2016 Mar 24.

25.

Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors.

Umlauft M, Radojewski P, Spanjol PM, Dumont R, Marincek N, Kollar A, Brunner P, Beyersmann J, Müller-Brand J, Maecke HR, Laimer M, Walter MA.

J Nucl Med. 2017 Jan;58(1):97-102. doi: 10.2967/jnumed.116.180687. Epub 2016 Sep 15.

26.

The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors.

Brunner P, Jörg AC, Glatz K, Bubendorf L, Radojewski P, Umlauft M, Marincek N, Spanjol PM, Krause T, Dumont RA, Maecke HR, Müller-Brand J, Briel M, Schmitt A, Perren A, Walter MA.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):468-475. doi: 10.1007/s00259-016-3486-2. Epub 2016 Aug 18.

PMID:
27539020
27.

2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA.

Thyroid. 2016 Oct;26(10):1343-1421. Erratum in: Thyroid. 2017 Nov;27(11):1462.

PMID:
27521067
28.

Reply: Somatostatin Receptor-Targeted Radiopeptide Therapy in Patients with Progressive Unresectable Meningioma.

Radojewski P, Dumont RA, Marincek N, Brunner P, Müller-Brand J, Maecke HR, Briel M, Walter MA.

J Nucl Med. 2016 Oct;57(10):1657-1658. Epub 2016 Jun 30. No abstract available.

29.

Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials.

Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M.

PLoS Med. 2016 Jun 28;13(6):e1002046. doi: 10.1371/journal.pmed.1002046. eCollection 2016 Jun.

30.

FOXC2 disease-mutations identified in lymphedema-distichiasis patients cause both loss and gain of protein function.

Tavian D, Missaglia S, Maltese PE, Michelini S, Fiorentino A, Ricci M, Serrani R, Walter MA, Bertelli M.

Oncotarget. 2016 Aug 23;7(34):54228-54239. doi: 10.18632/oncotarget.9797.

31.

Prostaglandins in the eye: Function, expression, and roles in glaucoma.

Doucette LP, Walter MA.

Ophthalmic Genet. 2017 Mar-Apr;38(2):108-116. doi: 10.3109/13816810.2016.1164193. Epub 2016 Apr 12. Review.

PMID:
27070211
32.

Planning and reporting of quality-of-life outcomes in cancer trials.

Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B; DISCO study group.

Ann Oncol. 2016 Jan;27(1):209. doi: 10.1093/annonc/mdv559. Epub 2015 Nov 25. No abstract available.

33.

On transcending the impasse of respiratory motion correction applications in routine clinical imaging - a consideration of a fully automated data driven motion control framework.

Kesner AL, Schleyer PJ, Büther F, Walter MA, Schäfers KP, Koo PJ.

EJNMMI Phys. 2014 Dec;1(1):8. doi: 10.1186/2197-7364-1-8. Epub 2014 Jun 17.

34.

Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study.

Schandelmaier S, von Elm E, You JJ, Blümle A, Tomonaga Y, Lamontagne F, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Cook DJ, Meade MO, Bucher HC, Kasenda B, Briel M.

Crit Care Med. 2016 Jan;44(1):130-7. doi: 10.1097/CCM.0000000000001369.

35.

Planning and reporting of quality-of-life outcomes in cancer trials.

Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B; DISCO study group.

Ann Oncol. 2015 Sep;26(9):1966-73. doi: 10.1093/annonc/mdv283. Epub 2015 Jun 30. Erratum in: Ann Oncol. 2016 Jan;27(1):209.

36.

The interactions of genes, age, and environment in glaucoma pathogenesis.

Doucette LP, Rasnitsyn A, Seifi M, Walter MA.

Surv Ophthalmol. 2015 Jul-Aug;60(4):310-26. doi: 10.1016/j.survophthal.2015.01.004. Epub 2015 Feb 4. Review.

PMID:
25907525
37.

Towards tailored radiopeptide therapy.

Radojewski P, Dumont R, Marincek N, Brunner P, Mäcke HR, Müller-Brand J, Briel M, Walter MA.

Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1231-7. doi: 10.1007/s00259-015-3030-9. Epub 2015 Mar 20.

PMID:
25792454
38.

[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)].

Poeppel TD, Boy C, Bockisch A, Kotzerke J, Buchmann I, Ezziddin S, Scheidhauer K, Krause BJ, Schmidt D, Amthauer H, Rösch F, Nagarajah J, Führer D, Lahner H, Pöpperl G, Hörsch D, Walter MA, Baum RP.

Nuklearmedizin. 2015;54(1):1-11; quiz N2. German.

PMID:
25683107
39.

Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma.

Dumont RA, Seiler D, Marincek N, Brunner P, Radojewski P, Rochlitz C, Müller-Brand J, Maecke HR, Briel M, Walter MA.

Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):46-55. eCollection 2015.

40.

Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.

Marincek N, Radojewski P, Dumont RA, Brunner P, Müller-Brand J, Maecke HR, Briel M, Walter MA.

J Nucl Med. 2015 Feb;56(2):171-6. doi: 10.2967/jnumed.114.147256. Epub 2015 Jan 15.

41.

18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET).

Bertolini R, Goepfert C, Andrieu T, Nichols S, Walter MA, Frey FJ, McCammon JA, Frey BM.

Prostate. 2015 Mar 1;75(4):348-59. doi: 10.1002/pros.22919. Epub 2014 Oct 30.

PMID:
25358634
42.

Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.

Kasenda B, Schandelmaier S, Sun X, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M; DISCO Study Group.

BMJ. 2014 Jul 16;349:g4539. doi: 10.1136/bmj.g4539. Erratum in: BMJ. 2014;349:4921. Kasenda, Benjamin [added]; Schandelmaier, Stefan [added]; Sun, Xin [added]; von Elm, Erik [added]; You, John [added]; Blümle, Anette [added]; Tomonaga, Yuki (8) Saccilotto, Ramon (9) Amstutz, Alain [added]; Bengough, Theresa [added]; etc..

43.

Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study.

Rosenthal R, Kasenda B, Dell-Kuster S, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla S, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Olu KK, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M.

Ann Surg. 2015 Jul;262(1):68-73. doi: 10.1097/SLA.0000000000000810.

44.

Indium-111 labeled gold nanoparticles for in-vivo molecular targeting.

Ng QK, Olariu CI, Yaffee M, Taelman VF, Marincek N, Krause T, Meier L, Walter MA.

Biomaterials. 2014 Aug;35(25):7050-7. doi: 10.1016/j.biomaterials.2014.04.098. Epub 2014 May 17.

PMID:
24840614
45.

FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.

DeGraff DJ, Grabowska MM, Case TC, Yu X, Herrick MK, Hayward WJ, Strand DW, Cates JM, Hayward SW, Gao N, Walter MA, Buttyan R, Yi Y, Kaestner KH, Matusik RJ.

Lab Invest. 2014 Jul;94(7):726-39. doi: 10.1038/labinvest.2014.64. Epub 2014 May 19.

46.

Prevalence, characteristics, and publication of discontinued randomized trials.

Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Schandelmaier S, Xin S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M.

JAMA. 2014 Mar 12;311(10):1045-51. doi: 10.1001/jama.2014.1361.

47.

Dysfunction of the stress-responsive FOXC1 transcription factor contributes to the earlier-onset glaucoma observed in Axenfeld-Rieger syndrome patients.

Ito YA, Goping IS, Berry F, Walter MA.

Cell Death Dis. 2014 Feb 20;5:e1069. doi: 10.1038/cddis.2014.8. Erratum in: Cell Death Dis. 2014;5:e1430.

48.

Genomics and anterior segment dysgenesis: a review.

Ito YA, Walter MA.

Clin Exp Ophthalmol. 2014 Jan-Feb;42(1):13-24. doi: 10.1111/ceo.12152. Epub 2013 Jul 29. Review.

PMID:
24433355
49.

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours.

Romer A, Seiler D, Marincek N, Brunner P, Koller MT, Ng QK, Maecke HR, Müller-Brand J, Rochlitz C, Briel M, Schindler C, Walter MA.

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):214-22. doi: 10.1007/s00259-013-2559-8. Epub 2013 Oct 2.

PMID:
24085501
50.

1,2,3-Triazoles as amide bond mimics: triazole scan yields protease-resistant peptidomimetics for tumor targeting.

Valverde IE, Bauman A, Kluba CA, Vomstein S, Walter MA, Mindt TL.

Angew Chem Int Ed Engl. 2013 Aug 19;52(34):8957-60. doi: 10.1002/anie.201303108. Epub 2013 Jul 5. No abstract available.

PMID:
23832715

Supplemental Content

Loading ...
Support Center